Systems biology approach highlights mechanistic differences between Crohn’s disease and ulcerative colitis
Pedro A. Ruiz(University of Zurich), Marja Talikka(Philip Morris International (Switzerland)), Manuel C. Peitsch(Philip Morris International (Switzerland)), Sylvain Gubian(Philip Morris International (Switzerland)), Hasmik Yepiskoposyan(Philip Morris International (Switzerland)), Ulrike Kogel(Philip Morris International (Switzerland)), Florian Calvino-Martin(Philip Morris International (Switzerland)), Kasper Renggli(Vectura (Germany)), Julia Hoeng(Philip Morris International (Switzerland))
Cited by 27
Related Papers
Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome
|Gut|2016|318
Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation
|Nature Communications|2017|312
Selective and Responsive Nanoreactors
|Advanced Functional Materials|2011|231
A lung/liver-on-a-chip platform for acute and chronic toxicity studies
|Lab on a Chip|2018|182
Protein cages and synthetic polymers: a fruitful symbiosis for drug delivery applications, bionanotechnology and materials science
|Chemical Society Reviews|2016|174